Wei Peng

Former Vice Chairman & General Manager at United Laboratories International Holdings Ltd.

Wei Peng

Wei Peng

Former Vice Chairman & General Manager at United Laboratories International Holdings Ltd.

Biography

Wei Peng is former Vice Chairman & General Manager at United Laboratories International Holdings Ltd. She received an undergraduate degree from Xi'an Jiaotong University and an MBA from Sun Yat-Sen University.

Overview
RelSci Relationships

26

Number of Boards

1

Birthday

1963

Age

56

Relationships
RelSci Relationships are individuals Wei Peng likely has professional access to. A relationship does not necessarily indicate a personal connection.

Vice President at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Vice President at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Executive Director & Vice President at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Chairman at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Executive Director at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Director, Production Factory at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Associate at Taxation Institute of Hong Kong

Relationship likelihood: Strong

Executive Director at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Non-Executive Director at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Independent Non-Executive Director at United Laboratories International Holdings Ltd.

Relationship likelihood: Strong

Paths to Wei Peng
Potential Connections via
Relationship Science
You
Wei Peng
Former Vice Chairman & General Manager at United Laboratories International Holdings Ltd.
Education
Undergraduate Degree
Class of 1983

Xian Jiaotong University is a school.

Career History
Vice Chairman & General Manager
2010 - 2012

United Laboratories International Holdings Ltd. operates as an investment company, which engages in the manufacturing and sale of medicines, and the bulk and intermediate products used to produce finished goods. It operates through the following segments: Intermediate Products, Bulk Medicine, and Finished Products. The Intermediate Products segment offers two major products, such as T-Octylammonium Clavulanate and 6-APA. The Bulk Medicine segment includes amoxicillin and insulin. The Finished Products segment includes the sale of antibiotics and non-antibiotics finished products, and capsule casings including Semi-synthetic penicillins antibiotics, Cephalosporins antibiotics, and Insulin products. The company was founded on March 6, 2006 and is headquartered in Hong Kong.

Boards & Committees
Member, Board of Directors
2010 - 2012

United Laboratories International Holdings Ltd. operates as an investment company, which engages in the manufacturing and sale of medicines, and the bulk and intermediate products used to produce finished goods. It operates through the following segments: Intermediate Products, Bulk Medicine, and Finished Products. The Intermediate Products segment offers two major products, such as T-Octylammonium Clavulanate and 6-APA. The Bulk Medicine segment includes amoxicillin and insulin. The Finished Products segment includes the sale of antibiotics and non-antibiotics finished products, and capsule casings including Semi-synthetic penicillins antibiotics, Cephalosporins antibiotics, and Insulin products. The company was founded on March 6, 2006 and is headquartered in Hong Kong.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Wei Peng. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Wei Peng's profile does not indicate a business or promotional relationship of any kind between RelSci and Wei Peng.